Events

Prof. Dr Jörg Rademann

Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin

Fragment-based drug discovery in academia: targeting the bacterial toxin pneumolysin and the cancer-related phosphatase SHP2 (…)

Karolina Bogusz, MSc

“The role of mTOR activity in regulating p150Glued-AP-2β protein interaction and controlling cellular Brg1 protein level and distribution” (…)

Dr Michał Koliński

Mossakowski Medical Research Institute, Polish Academy of Sciences, Poland

Development of multi-scale molecular modeling methods and their application to study complex protein systems. (…)

Dr. Said El Alaoui

COVALAB S.A.S., Biotechnology company in Bron, France

Building the Pipeline of Novel Therapeutic Antibodies: From the Bench to the clinic (…)

Dr hab. Łukasz Opaliński

Faculty of Biotechnology, University of Wrocław, Poland

NCN AWARD LECTURE: Multivalency in biomedicine. Career Development Series (…)

Prof. Krzysztof Liberek

Intercollegiate Faculty of Biotechnology of University of Gdańsk and Medical University of Gdańsk, Poland

FNP PRIZE LECTURE (…)

MSc Bartosz Baranowski

“Advanced methods of analyzing genomic neighborhoods to provide function prediction for new, uncharacterized gene families” (…)

MSc Joanna Grochowska

“Analysis of the role of selected proteins responsible for the processing and maturation of mitochondrial RNA in the regulation of the level of double-stranded RNA in human mitochondria” (…)

MSc Marta Żurawska

“Development of a multiplexed protein panel using a targeted proteomics approach for the study of CDK4/6-inhibitor resistance in breast cancer” (…)

MSc Justyna Antoniuk-Majchrzak

“Role of Swi6 and Rad51 proteins in cell protection against genetic instability” (…)

Dr Stefan Bresson

Wellcome Centre for Cell Biology and Institute of Cell Biology, University of Edinburgh, UK

The transcriptional and translational landscape of coronavirus OC43 infection (…)

MSc Ferran Masana

“Analysis of seed dormancy relationship with systemic acquired resistance” (…)